[COX-2 inhibitors in cancer prevention]. / Inhibidores de la ciclooxigenasa-2 en la prevención del cáncer.
Rev Clin Esp
; 205(9): 446-56, 2005 Sep.
Article
em Es
| MEDLINE
| ID: mdl-16194481
ABSTRACT
Chemoprevention of cancer is a reality today. Prevention of breast cancer with tamoxifen, of squamous cell skin cancer with actinic keratosis by diclofenac gel and in familial polyposis with anti-inflammatory drug (COX-2) celecoxib is considered of health care clinical use. The latter has received enormous attention by cancer investigators due to the attractiveness of its action mechanism and its possibilities of future clinical use in different neoplasms. Other anti-inflammatory drugs such as aspirin and sulindac also have a proven role in chemoprevention of cancer by cycloosygenase inhibition or of related substances. The review of the mechanisms by which these substances act gives us a clear idea of what it is and what the chemoprevention will be.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Anticarcinógenos
/
Inibidores de Ciclo-Oxigenase 2
/
Neoplasias
Idioma:
Es
Ano de publicação:
2005
Tipo de documento:
Article